Table 1.
Visit number | 0 | 1 | 2 | 3 | 4 | 5 |
Gestational weeks | <16 weeks | 12–15+6 weeks | ~20 weeks | ~28 weeks | ~36 weeks | Delivery |
Tasks | ||||||
Consent | x | |||||
Participant demographic data | x | |||||
OGTT/HbA1c prerandomisation (if previous GDM history) | x | |||||
Randomisation | x | |||||
Delivery of intervention | x | x | x | x | ||
OGTT to diagnose GDM | x | |||||
Assess adherence (app/diary) | x | x | x | x | ||
Maternal, fetal and neonatal outcomes | x | |||||
Qualitative data collection (interviews) | x | x |
*Assessments will be completed as near to the scheduled date as possible, depending on participant’s appointment date.
OGTT, oral glucose tolerance test.